Merit Medical Systems
(NASDAQ) MMSI
Merit Medical Systems Financials at a Glance
Market Cap
$4.08B
Revenue (TTM)
$1.52B
Net Income (TTM)
$128.49M
EPS (TTM)
$2.13
P/E Ratio
32.33
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$68.77
Volume
30,158
Open
$68.59
Price
$68.77
Volume
30,158
Open
$68.59
Previous Close
$68.77
Daily Range
$67.98 - $69.45
52-Week Range
$66.34 - $107.27
Dividend
$0.00
Beta (Volatility)
0.86 (Low)
Price
$68.77
Volume
30,158
Open
$68.59
Previous Close
$68.77
Daily Range
$67.98 - $69.45
52-Week Range
$66.34 - $107.27
MMSI News
MMSI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Merit Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
7,500
CEO
Martha Goldberg Aronson, MBA
Website
www.merit.comHeadquarters
South Jordan, UT 84095, US
MMSI Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
12%
Net Income Margin
8%
Return on Equity
9%
Return on Capital
8%
Return on Assets
5%
Earnings Yield
3.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.08B
Shares Outstanding
59.43M
Volume
30.16K
Short Interest
0.00%
Avg. Volume
786.66K
Financials (TTM)
Gross Profit
$738.27M
Operating Income
$184.72M
EBITDA
$332.05M
Operating Cash Flow
$297.37M
Capital Expenditure
$81.72M
Free Cash Flow
$215.65M
Cash & ST Invst.
$448.50M
Total Debt
$898.23M
Merit Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$393.94M
+10.9%
Gross Profit
$195.35M
+12.9%
Gross Margin
49.59%
N/A
Market Cap
$4.08B
N/A
Market Cap/Employee
$551.99K
N/A
Employees
7,400
N/A
Net Income
$38.01M
+36.0%
EBITDA
$91.75M
+26.1%
Quarterly Fundamentals
Net Cash
$449.73M
-7.6%
Accounts Receivable
$223.61M
+6.9%
Inventory
$333.70M
+9.0%
Long Term Debt
$887.35M
+13.1%
Short Term Debt
$10.88M
+5.3%
Return on Assets
4.78%
N/A
Return on Invested Capital
7.55%
N/A
Free Cash Flow
$76.99M
+19.4%
Operating Cash Flow
$98.51M
+43.3%